Cambridge Healthtech Institute’s Fourth Annual

Point-of-Care Diagnostics

Examining Rapid Diagnostics from the Clinic to Consumer

February 19-20, 2015 | The InterContinental San Francisco | San Francisco, CA
Part of the 22nd International Molecular Medicine Tri-Conference


Point-of-care testing is becoming a crucial component of healthcare both in an out of the clinical setting. Rapid care centers are now commonplace in many pharmacies and mobile diagnostics applications are allowing the consumer to take their health into their own hands. Cambridge Healthtech Institute's Fourth Annual Point-of-Care Diagnostics symposium will examine how point of care is being used in the clinic, in pharmacies, and by the consumer. Point-of-care test developers and end users will address barriers to implementation and present solutions to encourage adoption. Finally, innovative point-of-care and mobile health technologies will be presented to showcase the latest tools and provide insights into the future of the field.

Day 1 | Day 2 | Download Brochure | Symposia Brochure 

Thursday, February 19

7:30 am Registration and Morning Coffee


9:00 Chairperson’s Opening Remarks


The Evolving Approach to Direct-to-Patient Care and the Digital Revolution

Jeffrey A. Dubois, Ph.D., Vice President, Medical & Scientific Affairs, Nova Biomedical

The market for In Vitro Diagnostic (IVD) Testing is estimated to be $54 billion in 2013 with POCT representing 14-15% of the market based on several market research company reports. Since the evolution of blood glucose, blood gas, urinalysis, pregnancy, and coagulation testing in the mid-1990s the menu of POCTs has expanded from <10 tests available in 1995 to approximately 110 tests available today. The presentation overviews the historical, current, and future uses of POCT and poses some interesting questions to clinicians, clinical laboratory scientists, and regulators.

9:40 Point-of-Care Testing in Patient Care: A Real World Experience

Elizabeth A. Wagar, M.D., Professor and Chair, Laboratory Medicine, MD Anderson Cancer Center

All aspects of implementing and managing point-of-care testing from the laboratory director’s perspective will be examined, including management features, information transfer, quality programs, and regulatory requirements from the U.S. perspective. Experience from the outpatient and inpatient arenas will be described for two large medical centers, UCLA and the University of Texas MD Anderson Cancer Center. Discussion will be provided to answer pertinent point-of-care technology questions.

10:10 Point-of-Care Test Device Design: Practical Tips from the User

Valerie Ng, M.D., Ph.D., Chair, Laboratory Medicine & Pathology, Alameda Heath System/Highland General Hospital

This talk will present common user misuse issues with point of care testing, with suggestions for eliminating misuse through informed device design.

10:40 Coffee Break with Exhibit and Poster Viewing



Moderator: N. Reginald Beer, Ph.D., Medical Diagnostics Initiative Leader, Lawrence Livermore National Laboratory

Panelists: Philip L. Felgner, Ph.D., Director, Protein Microarray Laboratory, Infectious Disease; Project Scientist, Epidemiology, University of California, Irvine School of Medicine

Adithya Cattamanchi, M.D., Assistant Professor, University of California, San Francisco School of Medicine

Christine Hara, MPH, Consultant

12:15 pm POCT One-Step Molecular Diagnostic System Bring Complex Clinical Testing Directly to the Patient

Sabrina Li, CEO, Coyote Bioscience Company

Coyote Bioscience is dedicated to making break-through innovations in molecular diagnostics that brings complex clinical testing directly to the patient. We would like to introduce both of our lab-in-a-box instrumentation system based one PCR technology and our novel method of one-step gene test without nucleic acids extraction. You will see the first portable system for molecular diagnostics with general 0.2mL PCR tube capacity.

12:30 Session Break

12:40 Luncheon Presentation: Developing Innovative, Ultra-Rapid Diagnostics to Enable a ‘Test and Treat’ Solution to Infectious Diseases

Daniel Adlerstein, Ph.D ., Director, R&D, Atlas Genetics

Atlas Genetics has developed a diagnostic platform consisting of a small, low cost instrument and test-specific, disposable cartridges. The system provides an accurate, actionable test result in 30 minutes combining and integrating nucleic acid extraction, rapid-PCR and Atlas’ proprietary multiplex electrochemical detection. The reduced turn-around time improves patient care by reducing incorrect and empirical treatment and improving antibiotic stewardship.

1:15 Session Break


1:50 Chairperson’s Remarks

Keith Batchelder, M.D., Founder & CEO, Genomic Healthcare Strategies

2:00 Use of CLIA-Waived POC Tests in Pharmacy-Based Disease State Management Programs

Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy

Dr. Klepser will discuss the opportunities to use CLIA-waived point-of-care tests in community pharmacies.

2:30 Healthcare, Re-Imagined: Consumer Point-of-Care

Eric Saff, Chief Innovation Officer, HealthSpot

Eric Saff will draw on his experience in telehealth software and hardware platform in his presentation on consumer point-of-care. He will include a look at some of the biggest challenges to date, and where disruptive innovation can and should overcome these hurdles to meet new market opportunities and healthcare demands.

3:00 Refreshment Break with Exhibit and Poster Viewing

3:30 Community Pharmacies: The Face of Neighborhood Healthcare

Alex J. Adams, Pharm.D., IOM, Vice President, Pharmacy Programs, National Association of Chain Drug Stores (NACDS)

Community pharmacists are among the most accessible and trusted healthcare professionals; 95% of all Americans live within 5 miles of a pharmacies. Increasingly the public is turning to pharmacies for expanded services such as immunizations and point-of-care tests. This session will describe the community pharmacy landscape and opportunities to bring tests truly to the point of care.

4:00 Point-of-Care Testing in a Retail Health Clinic Setting

Daniel R. Kerls, MBA, OTR/L, Director, Ambulatory Operations, CVS MinuteClinic

With the growth of retail health clinics, more patients are choosing to obtain point of care testing in these settings.  In addition, employers are encouraging their employees to obtain biometric screenings in these settings.  This presentation will review the types of point of care testing, as well as the challenges and opportunities in this setting.

4:30 PANEL DISCUSSION: Consumer Healthcare: Future Perspectives

Moderator: Keith Batchelder, M.D., Founder & CEO, Genomic Healthcare Strategies


Donald Klepser, Ph.D., MBA, Associate Professor, Pharmacy Practice, University of Nebraska Medical Center College of Pharmacy

Allison Dering-Anderson, Pharm.D., RP, FAAIM, Clinical Assistant Professor, Pharmacy Practice, University of Nebraska Medical Center College of Pharmacy

Daniel R. Kerls, MBA, OTR/L, Director, Ambulatory Operations, CVS MinuteClinic

5:30 Close of Day

Day 1 | Day 2 | Download Brochure | Symposia Brochure 

Friday, February 20

8:00 am Morning Coffee


8:25 Chairperson’s Remarks

Jonathan O’Halloran, CSO and Co-Founder, Board, QuantuMDx Group

8:30 Development of a Handheld MDx and Sequencing Device 

Jonathan O’Halloran, CSO and Co-Founder, Board, QuantuMDx Group

QuantuMDx is developing a mobile, handheld DNA sequencing device for PGx, infectious disease and tumour profiling applications. We envision this device preventing pandemics via rapid identification in the field and a cloud-based monitoring system. The Internet of Life will be a real-time map of pathogen mutation and spread created using the data from a network of handheld DNA sequencers across the globe.

9:00 Neurotrack: Transforming the Diagnosis of Alzheimer’s 

Elli Kaplan, CEO, Neurotrack

9:30 Innovations in Telehealth and Care Delivery 

Lena Cheng, M.D., Vice President, Medical Affairs, Doctor on Demand

Doctor on Demand is the largest provider of video visits in the US. She will discuss how major changes in telehealth are expanding access to providers and facilitating provider interpretation and follow up to point-of-care diagnostics in medicine, genetics and behavioral health. She will discuss how partnerships between clinical providers and diagnostic companies can make point-of-care diagnosis and therapy a reality.

10:00 Re-imagining the Future of Point-of-Care Molecular Diagnostics for Infectious Disease

Hemanth Shenoi, Ph.D., Director, Business Development, Lucigen Corporation

Point of care testing can lower cost and improve healthcare outcomes; however molecular diagnostic tests are currently not available at POC. Through a case study example, attendees will gain an understanding of the product development and regulatory approval path for a CLIA-waivable molecular diagnostic point of care test platform.

10:15 Sponsored Presentation (Opportunity Available)

10:30 Coffee Break with Exhibit and Poster Viewing

11:00 FEATURED POSTER PRESENTATION: A Connected Point-of-Care Solution with Unparalleled Accuracy, Access and Affordability: Novel Platform Delivering Connected Point-of-Care Solution
Mohan Uttarwar, Cofounder and CEO, iNDx LifeCare Inc.iNDx LifeCare offers a Connected Point of Care (cPOC) platform with central lab sensitivity/reliability, multiplexing capability, quick turnaround time and connectivity to “the cloud”. As more distributed devices are replacing central locations for labs, connectivity has become a key feature in the success of POC devices. The iNDx LifeCare platform is based on optical waveguide technology, Q-SENS. Using an array of intersecting waveguides and a unique coupling method to avoid complex optics, Q-SENS technology excels where other sensing technologies have failed. The heart of the Q-SENS platform is small Silicon chip. Laser light coupled into a set of waveguides embedded into the Silicon chip, is guided to specially designed sensing areas where it excites fluorescent molecules. Highly efficient excitation through the ‘evanescent tail’ generates fluorescence which is collected back into a second set of waveguides. Our current design includes 32 different sensing areas on a 3mm X 3mm chip, allowing for testing of 1 to 32 different analytes on each chip from the same sample.  


Point-of-Care Testing (POCT) – Summary of an Evolving Approach to Direct Patient Care

Jeff Dubois, Vice President, Medical & Scientific Affairs, Nova Biomedical

12:30 Close of Symposium

Day 1 | Day 2 | Download Brochure | Symposia Brochure 

Premier Sponsors:   


Jackson Laboratory - small logo  


 Precision for Medicine 


Silicon Biosystems 

Thomson Reuters-Large